Researchers at People Science Explore the Effects of Cannabinoids on Sleep
by Bethan Rose
Dr. Raphael Mechoulam may just be the most significant person associated with cannabis science due to his discovery of the cannabis plant’s most infamous and intoxicating cannabinoid, tetrahydrocannabinol (THC). However, there is a chemist whose recognition is long overdue, especially considering the recent increase in cannabidiol (CBD) interest. Dr. Roger Adams was the first to isolate CBD—but who is he?
Adams (1889-1971) was an American organic chemist who assisted with determining the composition of substances such as vegetable oils, plant alkaloids, and cannabis. He was the department head of chemistry at the University of Illinois from 1926 to 1954, during which he conducted a wide range of chemistry-related research that contributed to cannabis science and wartime technology.
Adam’s contributions to organic chemistry are said to be rivaled only by his contributions to teaching since he taught more than 250 Ph.D. and post-doctoral students and developed a model graduate science program that is admired across the country. Adams and his students made a plethora of scientific advances, including showing CBD’s relationship to cannabinol (CBN) and THC as well as synthesizing CBN and THC analogs.
On top of his studies on cannabis, Adams looked at the role and misuse of science in war and totalitarianism during the early 20th century. In addition to studying Germany’s use of poison gas in trench warfare, Adams spent a lot of time on pharmaceutical research. In the book Bonds That Tie: Chemical Heritage and the Rise of Cannabis Research, J. N. Campbell explains that Adams’ penchant for assisting medical personnel stemmed from witnessing the power of chemical connections in pre-WWI Germany.
In 1940, Adams identified and synthesized the CBD cannabinoid. The 1944 Laguardia Committee Report stated, “We are indebted to Dr. Roger Adams, Professor of Chemistry at the University of Illinois…who supplied some of the active principles of marihuana.” His contributions to the demystification of cannabis compounds enabled many to conduct research and studies on the subject.
Two years after cannabis was banned by Congress, Adams received a Treasury Department license to work with cannabis oil. He studied the substance in his lab and presented his findings to the National Academy of Science. In 1942, the Office of Strategic Services (predecessor of the CIA) drew from Adams’ work in an attempt to develop a truth serum to be used for national security initiatives, though the efforts never panned out to anything substantial.
During his career, Adams faced significant rebuttal from Harry Anslinger, the anti-cannabis figure behind the Reefer Madness campaign of the 1930s. Anslinger thought that Adams was too enthusiastic about his discoveries regarding a federally illegal substance. In response to Adams’ claim that cannabis offered positive effects, Anslinger said, “In my opinion, this drug is bad for human consumption and should be painted so.”
Although CBD and its therapeutic uses only become clear later on, Adams did note its analgesic (pain-relieving) effects in the ’40s. As Adams conducted his work on cannabis, he was said to be risking his career and position since he had to stand up to those who were intolerant of cannabis, such as Anslinger. According to Yahoo Finance, much of Adams’ research was “quietly but aggressively terminated and subsequently buried by the combined forces of J. Edgar Hoover’s FBI and Harry Anslinger’s Federal Narcotics Bureau.”
According to the National Science & Technology Medals Foundation, Adams made other significant cannabis contributions, including the creation of the “Adams scale” to measure the potency of cannabis and the development of the Adams catalyst that many chemists use for hydrogenation reactions. Adams is also known for his discovery and synthesizing of hexahydrocannabinol (HHC), a cannabinoid found in small amounts naturally that is commonly produced synthetically today.
Adams also played a role in the origins of THC. While most honor the fact that Mechoulam was the first to discover the THC compound in 1964, some support the claim that it was actually Adams who identified THC for the first time. In fact, the truth lies in technicalities. Mechoulam was the first to identify and isolate THC, but it was Adams who first synthesized THC by modifying the molecular structure of other cannabinoids, especially CBD.
It is said that Adams was aware of the existence of a psychoactive compound in the cannabis plant and had a good idea of its molecular composition, but he never actually identified it. Some believe that he was unable to do so because he lacked access to the technology used by Mechoulam years later. However, he was the first to produce THC analogs, which “inferred” the compound’s existence within the plant. In summary, Mechoulam was the first to identify THC in the plant and Adams was the first to synthesize it.
Even with so many forces against him and his controversial research, Adams was able to publish over 60 papers, many of which were focused on cannabis science. In 1964, Adams was awarded the National Medal of Science for Chemistry “for superb contributions [to chemistry] as a scientist, teacher and imaginative leader in furthering the constructive interaction of academic and industrial scientists.” If not for his determination and hard work, it’s hard to say when CBD and its medicinal properties would have been discovered.
This was a very encouraging piece. It spurs the question, is there a sicsinc presentation out there that debunks scientifically Anslinger’s paranoia concerning cannabis?
In 2018, former President Donald Trump signed the Farm Bill into law. The Farm Bill is the federal government’s primary agricultural and food policy instrument. Every five years, Congress deals with renewing and revising the comprehensive bill. Before 2018, cannabis was not part of the conversation around farm subsidies or crop insurance. With the passing…
Four U.S. states—Minnesota, Ohio, Oklahoma, and Pennsylvania—stand a good chance at legalizing recreational cannabis this year. There’s also a slim chance of efforts being successfully voted on in the Carolinas, Indiana, and New Hampshire. Advocates are pushing harder for cannabis reform after achieving mixed results during last year’s midterm elections, which saw two victories (Missouri…
Thursday, Jan. 26, 2023, will be a date to remember for cannabis lobbyists in Greece because, on this day, the first-ever medicinal cannabis production plant was inaugurated at Examilia in Corinth. Drizzled in seaside charm, Corinth is renowned for its ancient Roman remains and now claims the limelight as a medical marijuana production hub. Tikun…
Nobody wants to spend time with paranoid Pete, but if you don’t choose your cannabis strains wisely, you could get flung into a portal of paranoia yourself. Funnily enough, a recent Marist poll found that almost a third of cannabis users in the U.S. use marijuana to ease anxiety or stress. A separate Marist poll…
Oklahomans’ cannabis vote ended on a sour note, a Canadian dispensary is facing backlash over cocaine sales, and Arizona law students are offering free expungement services. Let’s dive into this week’s cannanews. Oklahomans Vote on Cannabis Legalization Earlier this week, Oklahoma voters had a big decision to make on the ballot. Question 820 asked Oklahomans…
Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the…
Maryland and Delaware are exploring their cannabis policies, a Texas representative introduced another decriminalization bill, and New Orleans okayed cannabis-infused seltzers. Let’s…
Who would have thought that cannabis cultivation could be Alaska’s biggest earner? Over the course of the next eight years, marijuana cultivation…